바이오의약품용 플라스틱 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 폴리머 종류별(폴리염화비닐, 폴리에틸렌 테레프탈레이트, 폴리프로필렌, 기타), 용도별, 지역별, 경쟁별(2020-2030년)
Biopharma Plastics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Polymer Type (Polyvinyl Chloride, Polyethylene Terephthalate, Polypropylene, Others), By Application, By Region and Competition, 2020-2030F
상품코드:1841713
리서치사:TechSci Research
발행일:2025년 09월
페이지 정보:영문 186 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
바이오의약품용 플라스틱 시장은 2024년에 54억 7,000만 달러로 평가되었으며, 2030년에는 CAGR 5.23%로 73억 4,000만 달러에 달할 것으로 예측됩니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
54억 7,000만 달러
시장 규모 : 2030년
73억 4,000만 달러
CAGR : 2025-2030년
5.23%
급성장 부문
바이오리액터 백
최대 시장
아시아태평양
세계 바이오의약품용 플라스틱 시장은 바이오의약품 분야의 첨단 소재에 대한 수요 증가로 인해 변화의 시기를 맞이하고 있습니다. 폴리에틸렌, 폴리프로필렌, 폴리카보네이트 등의 폴리머를 포함한 바이오의약품용 플라스틱은 일회용 바이오프로세싱 시스템, 포장, 실험기구, 약물전달 시스템 등의 용도에 필수적입니다. 이 소재들은 내화학성, 무균성, 내구성으로 평가받고 있으며, 제품의 안전성과 유효성을 보장하는 데 필수적인 요소로 평가받고 있습니다. 바이오 제약 기업들이 오염 위험을 줄이고 업무 유연성을 높이기 위해 일회용 기술을 채택하는 경향이 강화되면서 이 시장은 점점 더 큰 추진력을 얻고 있습니다. 이러한 변화는 위생적인 제조 관행에 대한 관심이 높아진 포스트 팬데믹 시대에 특히 두드러집니다.
혁신적인 약물전달 및 맞춤형 의료는 엄격한 규제 기준을 견딜 수 있는 재료가 필요합니다. 바이오의약품용 플라스틱의 방출 제어 시스템 및 보호 포장에 대한 통합은 만성질환의 증가와 세계 인구의 고령화에 대응하여 그 유용성을 더욱 확대하고 있습니다. 이러한 인구 증가 추세는 의료비 지출 증가와 함께 탄탄한 수요 환경을 촉진하고 있습니다. 지속가능한 솔루션을 향한 움직임이 시장 역학에 영향을 미치고 있으며, 이해관계자들은 세계 환경 목표에 부합하는 친환경 플라스틱 대안을 모색하고 있습니다.
Biopharma Plastics Market was valued at USD 5.47 Billion in 2024 and is expected to reach USD 7.34 Billion by 2030 with a CAGR of 5.23%.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 5.47 Billion
Market Size 2030
USD 7.34 Billion
CAGR 2025-2030
5.23%
Fastest Growing Segment
Bioreactor Bags
Largest Market
Asia Pacific
The global biopharma plastics market is witnessing a transformative phase, driven by the escalating demand for advanced materials in the biopharmaceutical sector. Biopharma plastics, encompassing polymers such as polyethylene, polypropylene, and polycarbonate, are integral to applications including single-use bioprocessing systems, packaging, laboratory ware, and drug delivery systems. These materials are valued for their chemical resistance, sterility, and durability, making them indispensable in ensuring product safety and efficacy. The market has gained momentum as biopharmaceutical companies increasingly adopt single-use technologies to mitigate contamination risks and enhance operational flexibility, a shift that has been particularly pronounced in the post-pandemic era with heightened focus on hygienic manufacturing practices.
The market's evolution is underpinned by the growing complexity of biopharmaceutical production, where innovative drug delivery mechanisms and personalized medicine require materials that can withstand stringent regulatory standards. The integration of biopharma plastics in controlled release systems and protective packaging has further expanded their utility, catering to the rising prevalence of chronic diseases and the aging global population. This demographic trend, coupled with increased healthcare expenditure, is fostering a robust demand environment. The push towards sustainable solutions is influencing market dynamics, with stakeholders exploring eco-friendly plastic alternatives to align with global environmental goals.
Key Market Drivers
Rising Demand for Single-Use Bioprocessing Systems
The global biopharma plastics market is significantly driven by the increasing adoption of single-use bioprocessing systems, which have revolutionized manufacturing processes in the biopharmaceutical industry. These systems, utilizing plastics such as polyethylene and polypropylene, offer a cost-effective and contamination-free alternative to traditional stainless-steel setups, aligning with the industry's focus on enhancing production efficiency and safety. The shift towards single-use technologies has been accelerated by the need to reduce cross-contamination risks, a critical concern in the production of biologics and vaccines. This trend is particularly evident in the wake of global health crises, which have underscored the importance of scalable and flexible manufacturing solutions.
The demand is further supported by the growing complexity of biopharmaceutical products, including monoclonal antibodies and gene therapies, which require sterile and disposable components. Regulatory bodies worldwide are endorsing these systems, encouraging their widespread adoption through favorable guidelines. Additionally, the reduced need for extensive cleaning and validation processes associated with single-use systems translates into lower operational costs and faster turnaround times, appealing to both large-scale manufacturers and emerging biotech firms. As the biopharma sector continues to expand its pipeline, the reliance on these plastic-based solutions is expected to grow, fuelling market expansion throughout the 2020-2030F forecast period.
Key Market Challenges
Volatility in Raw Material Prices
The biopharma plastics market faces a significant challenge due to the volatility in raw material prices, which impacts production costs and profit margins. Polymers such as polyethylene and polypropylene are derived from petrochemical sources, making their prices susceptible to fluctuations in crude oil markets. This instability creates uncertainty for manufacturers, who must navigate unpredictable cost structures while maintaining competitive pricing. The challenge is compounded by the need to source high-quality raw materials that meet stringent regulatory standards, further increasing expenses during price surges.
This volatility can disrupt supply chains, leading to delays in production and potential shortages of critical components. For small and medium-sized enterprises, the inability to absorb these cost fluctuations poses a risk to their market presence. Industry players are compelled to explore alternative sourcing strategies or invest in price stabilization measures, which may require significant capital investment. Addressing this challenge will be crucial to ensuring the market's resilience over the 2020-2030F period.
Key Market Trends
Shift Towards Sustainable and Recyclable Plastics
A prominent trend in the biopharma plastics market is the shift towards sustainable and recyclable plastics, driven by increasing environmental consciousness and regulatory pressures. Manufacturers are investing in the development of bio-based polymers and recyclable materials that maintain the necessary properties for biopharmaceutical applications, such as sterility and chemical resistance. This trend aligns with global sustainability initiatives, encouraging the adoption of lightweight plastics that reduce carbon footprints during production and disposal.
The move towards eco-friendly solutions is also influencing consumer preferences, with healthcare providers and biopharma companies seeking greener alternatives to traditional plastics. This trend is expected to gain traction over the 2020-2030F period, as innovations in material science pave the way for scalable, sustainable options that meet industry standards.
Key Market Players
Saudi Basic Industries Corporation
BASF SE
Spectrum Plastics Group
Celanese Corporation
LyondellBasell Industries Holdings B.V.
DuPont de Nemours, Inc.
Tekni-Plex, Inc.
Solvay S.A.
Avantor, Inc.
Bormioli Pharma S.p.A.
Report Scope
In this report, the Global Biopharma Plastics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Biopharma Plastics Market, By Polymer Type:
Polyvinyl Chloride (PVC)
Polyethylene
Terephthalate (PET)
Polypropylene (PP)
Others
Biopharma Plastics Market, By Application:
Protective Wear
Containers
Bioreactor Bags
Syringes
Others
Biopharma Plastics Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Biopharma Plastics Market.
Available Customizations:
Global Biopharma Plastics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Disruptions: Conflicts, Pandemics, and Trade Barriers
5. Global Biopharma Plastics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Polymer Type (Polyvinyl Chloride (PVC), Polyethylene Terephthalate (PET), Polypropylene (PP), Others)
5.2.2. By Application (Protective Wear, Containers, Bioreactor Bags, Syringes, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
5.3.1. By Polymer Type
5.3.2. By Application
5.3.3. By Region
6. North America Biopharma Plastics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Polymer Type
6.2.2. By Application
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Biopharma Plastics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value & Volume
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Polymer Type
6.3.1.2.2. By Application
6.3.2. Mexico Biopharma Plastics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value & Volume
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Polymer Type
6.3.2.2.2. By Application
6.3.3. Canada Biopharma Plastics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value & Volume
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Polymer Type
6.3.3.2.2. By Application
7. Europe Biopharma Plastics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Polymer Type
7.2.2. By Application
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Biopharma Plastics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value & Volume
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Polymer Type
7.3.1.2.2. By Application
7.3.2. Germany Biopharma Plastics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value & Volume
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Polymer Type
7.3.2.2.2. By Application
7.3.3. United Kingdom Biopharma Plastics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value & Volume
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Polymer Type
7.3.3.2.2. By Application
7.3.4. Spain Biopharma Plastics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value & Volume
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Polymer Type
7.3.4.2.2. By Application
7.3.5. Italy Biopharma Plastics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value & Volume
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Polymer Type
7.3.5.2.2. By Application
8. Asia-Pacific Biopharma Plastics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Polymer Type
8.2.2. By Application
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Biopharma Plastics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value & Volume
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Polymer Type
8.3.1.2.2. By Application
8.3.2. India Biopharma Plastics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value & Volume
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Polymer Type
8.3.2.2.2. By Application
8.3.3. South Korea Biopharma Plastics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value & Volume
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Polymer Type
8.3.3.2.2. By Application
8.3.4. Japan Biopharma Plastics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value & Volume
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Polymer Type
8.3.4.2.2. By Application
8.3.5. Australia Biopharma Plastics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value & Volume
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Polymer Type
8.3.5.2.2. By Application
9. South America Biopharma Plastics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Polymer Type
9.2.2. By Application
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Biopharma Plastics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value & Volume
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Polymer Type
9.3.1.2.2. By Application
9.3.2. Argentina Biopharma Plastics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value & Volume
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Polymer Type
9.3.2.2.2. By Application
9.3.3. Colombia Biopharma Plastics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value & Volume
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Polymer Type
9.3.3.2.2. By Application
10. Middle East and Africa Biopharma Plastics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Polymer Type
10.2.2. By Application
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Biopharma Plastics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value & Volume
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Polymer Type
10.3.1.2.2. By Application
10.3.2. Saudi Arabia Biopharma Plastics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value & Volume
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Polymer Type
10.3.2.2.2. By Application
10.3.3. UAE Biopharma Plastics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value & Volume
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Polymer Type
10.3.3.2.2. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Product Launches
12.2. Mergers & Acquisitions
12.3. Technological Advancements
13. Global Biopharma Plastics Market: SWOT Analysis
